Corline Biomedical AB (STO:CLBIO)
12.45
0.00 (0.00%)
Aug 22, 2025, 5:18 PM CET
Corline Biomedical AB Market Cap
Corline Biomedical AB has a market cap or net worth of 304.91 million as of August 22, 2025. Its market cap has increased by 5.49% in one year.
Market Cap
304.91M
Enterprise Value
293.18M
Revenue
13.92M
Ranking
n/a
PE Ratio
n/a
Stock Price
12.45
Market Cap Chart
Since June 3, 2015, Corline Biomedical AB's market cap has increased from 97.97M to 304.91M, an increase of 211.24%. That is a compound annual growth rate of 11.74%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 21, 2025 | 304.91M | 61.59% |
Dec 30, 2024 | 188.69M | -41.07% |
Dec 29, 2023 | 320.21M | 61.61% |
Dec 30, 2022 | 198.15M | -36.85% |
Dec 30, 2021 | 313.77M | 25.86% |
Dec 30, 2020 | 249.29M | -0.33% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Swedish Orphan Biovitrum AB | 97.94B |
Sectra AB | 68.21B |
Getinge AB | 56.43B |
Medicover AB | 41.07B |
Camurus AB | 40.02B |
Asker Healthcare Group AB | 37.36B |
AddLife AB | 20.92B |
BioArctic AB | 20.86B |